Abstract:Recently, accumulating evidence revealed that nonalcoholic fatty liver disease (NAFLD) is highly associated with the dysbiosis of gut microbiota. Jiang Zhi Granule (JZG), which is composed of five widely used Chinese herbs, has shown hypolipidemic effect, while whether such effect is mediated by gut microbiota is still unclear. Here, we found that both low and high doses of JZG (LJZ and HJZ) could improve hepatic steatosis and function, as well as insulin resistance in NAFLD mice. 16S rRNA gene sequencing revealed that JZG treatment could reverse the dysbiosis of intestinal flora in NAFLD mice, exhibiting a dose-dependent effect. Notably, HJZ could significantly reduce the relative abundance of Desulfovibrionaceae, while increasing the relative abundance of such as S24_7 and Lachnospiraceae. PICRUSt analysis showed that HJZ could significantly alter the functional profile of gut microbiota, including the reduction of the lipopolysaccharide biosynthesis and sulfur metabolism pathway, which is verified by the decreased levels of fecal hydrogen sulfide (H2S) and serum lipopolysaccharide binding protein (LBP). In addition, hepatic mRNA sequencing further indicated that the HJZ group can regulate the peroxisome proliferator-activated receptor (PPAR) pathway and inflammatory signaling pathway, as validated by RT-PCR and Western blot. We also found that different doses of JZG may regulate lipid metabolism through differentiated pathways, as LJZ mainly through the promotion of hepatic lipid hydrolysis, while HJZ mainly through the improvement of hepatic lipid oxidation. Taken together, JZG could modulate gut dysbiosis with dose-effect, alleviate inflammation level, and regulate hepatic lipid metabolism, which may subsequently contribute to the improvement of NAFLD. Our study revealed the underlying mechanisms in the improvement of NAFLD by a Chinese herbal compound, providing future guidance for clinical usage.

Observation on therapeutic efficacy of Jiangzhi granules for treatment of HAART-related hyperlipidemia in 29 patients

Effect of Chinese Medicinal Granules on Dyslipidemia Associated with Highly Active Antiretroviral Therapy: a Multi-Centered,Randomize-Controlled Trial

Clinical Observations on 100 HIV/AIDS Cases Treated with Chinese Herb Aining Granule Plus HAART

Effect of Jiangzhi Shuxin Decoction for Chronic Stable Angina Pectoris:An Observation of 79 Cases

Clinical Efficacy of Jiangzhiligan Granules Combined with Simvastatinin in Treatment of Non-alcoholic Fatty Liver Disease

Effects of Yuzhi Granules on Hyperlipidemia and the Levels of Soluble Intercellular Adhesion Molecule-1 and Soluble Vascular Cell Adhesion Molecule-1

Multi-centered, randomized controlled clinical study on Chinese medicine formula particles for hyperlipidaemia associated with highly active antiretroviral therapy

Observation of Therapeutic Effects of Shouwu Granules for Patients with Hyperlipidemia and Hypercoagulable State

Effects of traditional Chinese medicine combined with HAART therapy on the level of toll like receptors mRNA in AIDS patients with incomplete immune reconstitution

Chinese Herbal Medicine for HIV/AIDS： a Systematic Review and Meta-analysis of Randomized Clinical Trials

Effects of Immune 2 Granule Combined with HAART Therapy treatment on IL-2 and IL-10 mRNA level of HIV/AIDS with Incomplete Immune Recovery

Clinical Observation of Gankang Granules in Treating Chronic Hepatitis B

Exploration of potential mechanism of Sanhua Jiangzhi granules for the treatment of hyperlipidemia based on network pharmacology and experimental verification

Effect of Chinese Herbal Medicine Jinlida Granule in Treatment of Patients with Impaired Glucose Tolerance.

Effect of Shuanghu Qinggan Granule () and Yigan Yiqi Jieyu Granule () Plus Lamivudine on Chronic Hepatitis B Patients: A Randomized Double-Blind Placebo-Controlled Trial.

Clinical Study on Effect of Jiangan Jiangzhi Pill in Treating Nonalcoholic Fatty Liver Diseases

[Effect of Xiaomi Granules in Treating 40 Patients of HIV/AIDS Oral Candidiasis].

[Experimental Studies on Blood Lipid Regulating Effects of Shuanghua Granules].

Clinical Observation on Treatment of Diabetic Nephropathy with Jin Shui-Bao Capsules and Ze-huang Granule

Structural and Functional Modulation of Gut Microbiota by Jiangzhi Granules during the Amelioration of Nonalcoholic Fatty Liver Disease

Jiangzhi granule attenuates non-alcoholic steatohepatitis through modulating bile acid in mice fed high-fat vitamin D deficiency diet